Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial

	Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial
	Yang, Jiaxin 2; Wu, Xiaohua 2; Zhu, Jianqing 3; Song, Liang 4; Feng, Yanling 5; Wang, Jing 1; Wu, Lingying 6; Liu, Ziling 7; Gao, Yunong 8; Wang, Danbo 9
刊名	GYNECOLOGIC ONCOLOGY
	2021-08-01
卷号	162
ISSN号	0090-8258
资助项目	GlaxoSmithKline
WOS研究方向	Oncology ; Obstetrics & Gynecology
语种	英语
出版者	ACADEMIC PRESS INC ELSEVIER SCIENCE
WOS记录号	WOS:000687070800028
资助机构	GlaxoSmithKline
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/125038]
专题	中国科学院合肥物质科学研究院
作者单位	1.Hunan Canc Hosp, Changsha, Peoples R China 2.Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China 3.Univ Chinese Acad Sci, Canc Hosp, Beijing, Peoples R China 4.West China Second Univ Hosp, Chengdu, Peoples R China 5.Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China 6.Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China 7.First Hosp Jilin Univ, Changchun, Peoples R China 8.Peking Univ Canc Hosp & Inst, Beijing, Peoples R China 9.China Med Univ, Canc Hosp, Shenyang, Liaoning, Peoples R China 10.Harbin Med Univ, Canc Hosp, Harbin, Peoples R China
推荐引用方式 GB/T 7714	Yang, Jiaxin,Wu, Xiaohua,Zhu, Jianqing,et al. Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial[J]. GYNECOLOGIC ONCOLOGY,2021,162.
APA	Yang, Jiaxin.,Wu, Xiaohua.,Zhu, Jianqing.,Song, Liang.,Feng, Yanling.,...&Dong, Juan.(2021).Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial.GYNECOLOGIC ONCOLOGY,162.
MLA	Yang, Jiaxin,et al."Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial".GYNECOLOGIC ONCOLOGY 162(2021).